Related Experiment Video
Updated: Nov 14, 2025
03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.6K
COVID-19 in early 2021: current status and looking forward
Chengdi Wang1, Zhoufeng Wang1, Guangyu Wang2
1Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
Signal Transduction and Targeted Therapy
|March 9, 2021
Summary
The COVID-19 pandemic, caused by SARS-CoV-2, has seen rapid advancements in diagnostics, treatments, and vaccines within a year. This review covers key developments in epidemiology, virology, and AI-assisted diagnosis to combat the global health crisis.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- The emergence of SARS-CoV-2 in late 2019 led to a global pandemic, infecting over 100 million and causing 2 million deaths.
- The rapid spread necessitated swift research into the virus's epidemiology, virology, and pathogenesis.
Purpose of the Study:
- To summarize current knowledge on COVID-19, covering epidemiology, virology, pathogenesis, diagnosis, treatment, and vaccine development.
- To highlight the unprecedented speed of scientific and medical advancements in response to the pandemic.
- To provide a timeline of critical events and milestones in COVID-19 research and development.
Main Methods:
- Review of scientific literature and public health data related to SARS-CoV-2.
- Analysis of the timeline of diagnostic, therapeutic, and vaccine development.
- Inclusion of artificial intelligence applications in disease diagnosis.
Main Results:
- Diagnostics, antiviral drugs, and vaccines were developed and approved within one year of virus discovery.
- Significant progress was made across multiple research areas, including epidemiology, virology, and AI in diagnostics.
- The review details specific dates for critical developments, illustrating the rapid pace of response.
Conclusions:
- The global scientific community collaborated effectively to combat the COVID-19 pandemic.
- Continued rapid evolution of research and development is expected in the near future.
- Understanding the timeline of these advancements is crucial for appreciating the response to the pandemic.
More Related Videos
Related Concept Videos
01:08Prevalence and Incidence
1.1K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.1K
01:18Steps in Outbreak Investigation
324
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
324
01:29Issues And Trends In Healthcare Delivery System
6.0K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K
01:26Principles of Disease Surveillance
322
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
322
01:20COPD: Pathogenesis and Clinical Features
1.5K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
01:05Single Nucleotide Polymorphisms-SNPs
17.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K